Bangalore, Karnataka -- (SBWIRE) -- 04/01/2016 -- Bacterial conjunctivitis, which affects either one or both the eyes, is an extremely contagious eye condition wherein the conjunctiva is infected. Staphylococci, streptococci, gonococci, and Chlamydia are some of the causative agents of bacterial conjunctivitis. Extremely pathogenic bacteria such as Chlamydia trachomatis and Neisseria gonorrhea cause severe bacterial conjunctivitis. Antibiotics help in eradicating the microbes, resulting in faster clearance of the symptoms. Broad-spectrum antibiotics such as Besivance, Zymaxid, Maxitrol, and AzaSite, in the form of antibiotic pills, ointment, or eye drops help treat the infection. Fluoroquinolones, macrolides, aminoglycosides, and phenicols are among the different classes of antibiotics that are commonly prescribed to treat the condition.

Report forecast the global bacterial conjunctivitis drugs market to grow at a CAGR of 2.77% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global bacterial conjunctivitis drugs market for 2015-2020. To calculate the market size, it considers revenue generated from the sales of branded and generic drugs along with over-the-counter (OTC) drugs used to treat bacterial conjunctivitis.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Bacterial Conjunctivitis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Akorn
- Alcon
- Allergan
- Bausch & Lomb

Other prominent vendors
- Bayer
- Daiichi Sankyo
- F. Hoffmann-La Roche
- InSite Vision
- Merck
- Nicox
- Novartis
- Perrigo
- Pfizer
- Santen Pharmaceutical
- Shire
- Valeant Pharmaceuticals

Market driver
- Rising awareness about infections
- For a full, detailed list, view our report

Market challenge
- Patent expiry of drugs
- For a full, detailed list, view our report

Market trend
- Patient assistance programs
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 57 pages "Global Bacterial Conjunctivitis Drugs Market 2016-2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Overview: Bacterial conjunctivitis, Pipeline analysis, Antimicrobial resistance, Legislation relating to antibiotic use in US, Market landscape, Market segmentation by drug class, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-bacterial-conjunctivitis-drugs-market-2016-2020

Related Reports:

Global Orthobiologics Market 2016-2020; visit - http://www.drugpipeline.net/technavio/global-orthobiologics-market-2016-2020

Global Dermatophytic Onychomycosis Market 2016-2020; visit - http://www.drugpipeline.net/technavio/global-dermatophytic-onychomycosis-market-2016-2020

Global Cochlear Implant Market 2016-2020; visit - http://www.drugpipeline.net/technavio/global-cochlear-implant-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.